| 12:00 – 12:05 |
Welcome remarks |
Prof. Thomas Berg, EASL Secretary General |
| 12:05 – 12:10 |
Opening statement |
MEP Cyrus Engerer, Actions to tackle health inequities at EU level |
| 12:10 – 12:30 |
Session 1: The increasing burden of liver diseases in Europe |
|
|
Results of the EASL-Lancet Commission |
Prof. Tom H. Karlsen, Co-Chair of the EASL-Lancet Commission |
|
Non-communicable liver diseases in Europe: the role of the European Centre for Disease Prevention and Control (ECDC) |
MEP Radan Kanev |
| 12:30 – 12:55 |
Session 2: Promoting prevention, care, and targeted screening for high-risk groups for liver cancer |
|
|
The increasing prevalence of liver diseases in Europe and the high-risk groups for liver cancer |
Prof. Peter Jepsen, EASL Liver Cancer Task Force |
|
The integration of high-risk groups in national strategies: The French case |
Prof. Pierre Nahon, EASL Expert |
|
Portugal’s harm reduction policies: addressing high risk behaviour and preventing liver diseases |
MEP Sara Cerdas |
|
Access to care and surveillance for highly stigmatised groups |
Roberto Pérez Gayo, Correlation European Harm Reduction Network |
| 12:55 – 13:10 |
Q&A with the public |
All speakers |
| 13:10 – 13:15 |
Closing remarks |
Prof. Maria Buti, EASL EU Policy Councillor |
